Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis

Objective. The multibiomarker disease activity (MBDA) blood test has been clinically validated as a measure of disease activity in patients with RA. We aimed to estimate the effect of the MBDA test on physical function for patients with RA (based on HAQ), quality-adjusted life years and costs over 1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Oxford)
Main Authors: Michaud, Kaleb, Strand, Vibeke, Shadick, Nancy A., Degtiar, Irina, Ford, Kerri, Michalopoulos, Steven N., Hornberger, John
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536857/
https://ncbi.nlm.nih.gov/pubmed/25877911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kev023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados